INTENT (EXPECTED OUTCOMES)

- All MT patients who receive TXA will have initial dose administered < 3 hours from time of injury.
- All patients receiving >1 unit of blood product also receive calcium.
- All patients receive calcium after every 4 units of blood product.
- All MT patients receive transfusion of FFP and RBC in a ratio between 1:1 and 1:2.
- All MT patients receive platelet or WB transfusion.
- All MT patients receive cryoprecipitate or WB.

PERFORMANCE/ADHERENCE MEASURES

- All MT patients who receive TXA will have initial dose administered < 3 hours from time of injury.
- All MT patients will receive TXA, unless ROTEM® data indicates no TXA indicated
- All patients receiving > 1 units of blood product also receive calcium.
- All patients receive calcium after every 4 units of blood product.
- All MT patients receive transfusion of FFP and RBC in a ratio between 1:1 and 1:2.
- All MT patients receive platelet or WB transfusion.
- All MT patients receive cryoprecipitate or WB

DATA SOURCES

- Patient Record
- Department of Defense Trauma Registry (DoDTR)
- Theater Medical Data Store

SYSTEM REPORTING & FREQUENCY

The above constitutes the minimum criteria for PI monitoring of this CPG. System reporting will be performed annually; additional PI monitoring and system reporting may be performed as needed.

The system review and data analysis will be performed by the JTS Chief, JTS Program Manager, and the JTS PI Branch.